Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

BioScience Health Innovations Inc

BHIC ✓ COMPLIANTFree checks used up today ☆ Track — members

OTC · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: N/A

Last Close

$6.95

▼ -2.25%

Market Cap $81.68M · Vol 201

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$81.68M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

67.12

Momentum

Beta

N/A

vs Market

52W High

$9.98

28.76% below

52W Low

$1.59

1,266.26% above

Volume

201

Avg 5.38K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

57.01%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, BioScience Health Innovations Inc (BHIC) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BHIC pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+26.65%

+7.42%

+66.36%

+297.14%

YTD

N/A

-80.72%

-46.04%

Financials & Valuation

TTM · Annual

Total Revenue	$5.69M
Net Income	$642.09K
Revenue Growth (YoY)	-41.03%
Gross Margin	56.97%
Operating Margin	12.64%
Net Profit Margin	11.29%
ROE	N/A
ROA · ROIC	55.72% · 55.53%

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	11.75M

Technical Indicators

50-Day SMA	$4.73
200-Day SMA	$4.07
RSI (14)	67.12
Beta	N/A
52-Week High	$9.98
52-Week Low	$1.59

Volume Today	201
Avg Daily Volume (30D)	5.38K
Relative Volume	0.04x
Volatility (10D)	157.38
Volatility (30D)	165.81
Free Float	57.01%

Analyst Consensus

N/A

Current Price $6.95

Mean Target N/A

52W Low$1.59 52W High$9.98

Current

Target

$1.59 $9.98

Current Analyst target

· 0 analysts

Identifiers

ExchangeOTC

FIGIN/A

ISINUS67012M2052

CountryUSA

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Company +1.28% JNJ Johnson & Johnson +1.10% ABBV AbbVie Inc. +0.58% NVS Novartis AG +1.60% NOVN.S Novartis AG +1.52%

Company Profile

BioScience Health Innovations, Inc., formerly Nowtransit Inc., is engaged in selling Be On-Guard Mouth Spray, Be On-Guard Nasal Spray, Be On-Guard Brain Fog Support, ADHD 365 maximum brain support, EZ Safer Surface Cleaner, NeuroPro Plus, a patent pending combination of pharmaceutical grade methylene blue and vitamin C, TBI-365 to elevate brain health and wellness with pharmaceutical grade methylene blue, glucine, nac and niacinamide and Metabolism+ to enhance metabolism. The Company’s targeted markets include Dementia and Alzheimer’s disease, ADHD and ADD, Long Covid, General Energy, Traumatic Brain Injury, Mild Cognitive Decline, GLP-1 Weight Loss, Sleep Improvement, Epilepsy and Seizure Reduction and Nasal Health and Allergy.